Principal Scientist (Director), Clinical Research, Atherosclerosis
Merck Sharp & Dohme is hiring for Principal Scientist (Director), Clinical Research, Atherosclerosis in USA - New Jersey - Rahway. Executive level, $256k–$403k a year stated. First seen November 3, 2026; open as of November 13, 2026. Jobs taken straight from company career pages — no aggregator in between.
With Destava: How well do you fit? · Tailor my résumé · Write a cover letter
- Company
- Merck Sharp & Dohme
- Where
- USA - New Jersey - Rahway
- Level
- Executive
- Pay stated
- $256k–$403k a year
- First seen
- November 3, 2026
- Listed via
- Workday
What the posting says
Job Description The Director (Principal Scientist) has primary responsibility for the planning and directing clinical research activities involving new or marketed medicines in the Atherosclerosis section of the Atherosclerosis & Metabolism therapeutic area. Our company's Atherosclerosis & Metabolism medicines span all phases of clinical development (pre-clinical to post-licensure). The Director will manage the entire cycle of clinical development for late-stage studies, including study design, initiation, execution, monitoring, analysis, regulatory reporting, and publication. Specifically,…
Read more and apply on Merck Sharp & Dohme's site
More jobs like this
Senior Scientist, Technology Development
Save to applyPrincipal Scientist, Parenteral ExM MS&T
Save to applyResearch Scientist III
Save to applyScientist, Clinical Diagnostics
Save to apply
See all 55 Medical Scientists, Except Epidemiologists jobs in New York
A search agent finds the jobs this list misses: the ones that mean the same without the same words. Have Destava watch for principal scientist (director), clinical research, atherosclerosis jobs in USA - New Jersey - Rahway, new matches every morning on your own account.
This page includes information from the O*NET 31.0 Database by the U.S. Department of Labor, Employment and Training Administration (USDOL/ETA). Used under the CC BY 4.0 license. O*NET® is a trademark of USDOL/ETA.